|
gptkbp:instance_of
|
gptkb:pharmaceuticals
|
|
gptkbp:approves
|
gptkb:United_States
|
|
gptkbp:atccode
|
S01 AE08
|
|
gptkbp:brand
|
gptkb:Zymaxid
|
|
gptkbp:class
|
gptkb:fluoroquinolone
|
|
gptkbp:clinical_trial
|
Phase 3
|
|
gptkbp:clinical_use
|
ophthalmic infections
|
|
gptkbp:contraindication
|
pregnancy
lactation
hypersensitivity to moxifloxacin
|
|
gptkbp:dosage_form
|
gptkb:Software_Solutions
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:financial_support
|
shake well before use
do not touch dropper tip
discard after 28 days of opening
|
|
gptkbp:form
|
single-use vial
multi-dose bottle
|
|
gptkbp:formulation
|
gptkb:cream
|
|
gptkbp:healthcare
|
2003-12-19
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Zymaxid
|
|
gptkbp:indication
|
conjunctivitis
|
|
gptkbp:ingredients
|
gptkb:moxifloxacin
|
|
gptkbp:interacts_with
|
gptkb:sucralfate
antacids
iron supplements
|
|
gptkbp:lifespan
|
13 hours
|
|
gptkbp:manufacturer
|
gptkb:Allergan
|
|
gptkbp:marketed_as
|
gptkb:Zymaxid_solution
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:packaging
|
gptkb:bottle
|
|
gptkbp:pharmacokinetics
|
bactericidal
topical absorption
|
|
gptkbp:provides_guidance_on
|
gptkb:American_Academy_of_Ophthalmology
gptkb:Infectious_Diseases_Society_of_America
|
|
gptkbp:requires
|
gptkb:true
|
|
gptkbp:route_of_administration
|
topical
ocular
|
|
gptkbp:shelf_life
|
2 years
|
|
gptkbp:side_effect
|
dry eyes
eye irritation
taste disturbance
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:structure
|
C21 H24 FN3 O4 S
|
|
gptkbp:used_for
|
bacterial infections
|
|
gptkbp:bfsParent
|
gptkb:Bausch_+_Lomb_Eye_Products_Inc.
gptkb:Valeant_Pharmaceuticals
|
|
gptkbp:bfsLayer
|
6
|